Get Liraglutide Online — From $179/Month
Real Liraglutide prescribed by licensed US clinicians. ~5-8% body weight body weight on average. First-generation daily GLP-1. Brand names: Saxenda, Victoza. Now available as generic.
✓ No insurance needed · ✓ Ships in 5-7 days · ✓ Cancel anytime
Liraglutide is a first-generation GLP-1 receptor agonist approved as Saxenda for weight loss and Victoza for type 2 diabetes. It requires daily subcutaneous injection. As of 2024, generic liraglutide is available, dropping the cost by roughly 70%.
Overview
Liraglutide was developed by Novo Nordisk, with Victoza approved in 2010 for type 2 diabetes and Saxenda approved in 2014 for weight loss. It was the first long-acting GLP-1 with sufficient half-life (~13 hours) for once-daily dosing — a significant improvement over earlier options like exenatide. The first authorized generic version of liraglutide launched in late 2024.
How Liraglutide Works
Liraglutide is a 31-amino-acid peptide modeled on GLP-1, with a fatty-acid linker that binds to albumin. Same mechanisms as semaglutide (appetite suppression, slowed gastric emptying, glucose-dependent insulin, glucagon suppression) but with daily dosing required.
Dosing & Schedule
Saxenda titration over 5 weeks:
- Week 1: 0.6 mg daily
- Week 2: 1.2 mg daily
- Week 3: 1.8 mg daily
- Week 4: 2.4 mg daily
- Week 5+: 3.0 mg daily (maintenance)
Victoza maximum is 1.8 mg daily for diabetes.
Effectiveness — Trial Data
SCALE trial (Saxenda 3.0 mg, 56 weeks): 5-8% average weight loss vs. 2.6% placebo. Less effective than semaglutide or tirzepatide but more affordable in generic form.
Side Effects
Common: nausea (40%), diarrhea (21%), vomiting (16%), constipation (19%), headache (14%), fatigue (8%). Most GI effects peak in early weeks and improve.
Cost — How Much Liraglutide Costs in 2026
Liraglutide pricing:
- Saxenda brand: $1,349/mo
- Victoza brand: $815-1,200/mo
- Generic liraglutide: ~$450/mo (launched late 2024)
Who Is Liraglutide For?
FDA-approved for chronic weight management (Saxenda) in adults BMI ≥30, or ≥27 with comorbidity, and pediatric ≥12 with high BMI. Victoza is approved for type 2 diabetes including pediatric ≥10.
Liraglutide Alternatives
Alternatives: Semaglutide (weekly, stronger results), Tirzepatide.